AAP
OPRX icon

Arax Advisory Partners’s OptimizeRx OPRX Stock Holding History

Arax Advisory Partners’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8K Buy
2,236
+2,204
+6,888% +$12.7K ﹤0.01% 4218
2026
Q1 		$201 Sell
32
-58
-64% -$539 ﹤0.01% 3537
2025
Q4 		$1.1K Sell
90
-235
-72% -$3.84K ﹤0.01% 3457
2025
Q3 		$6.66K Buy
+325
New +$5.16K ﹤0.01% 2772
2025
Q1 		– Sell
-126
Closed -$613 – 2938
2024
Q4 		$613 Buy
+126
New +$704 ﹤0.01% 2286

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Arax Advisory Partners's OPRX Position: Q2 2026 in Review

Arax Advisory Partners increased its OptimizeRx (OPRX) stake by 6,888% in Q2 2026, buying an estimated $12.7K and bringing the position to 2,236 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4218.

Arax Advisory Partners first reported a position in OPRX in Q4 2024 and has held it in 5 quarters since. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Arax Advisory Partners held 2,236 shares of OptimizeRx worth $12.8K as of Q2 2026.
  • Arax Advisory Partners bought 2,204 OptimizeRx shares in Q2 2026, an estimated $12.7K.
  • OptimizeRx made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4218 holding.
  • Arax Advisory Partners first reported a position in OptimizeRx in Q4 2024 and has held it in 5 quarters since.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.